River Road Asset Management’s Royalty Pharma RPRX Stock Holding History

River Road Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.5M	Sell	383,839 -23,530	-6%	-$1.22M	0.24%	99
2026 Q1	$19.5M	Sell	407,369 -111,285	-21%	-$4.87M	0.22%	102
2025 Q4	$20M	Sell	518,654 -20,359	-4%	-$776K	0.22%	100
2025 Q3	$19M	Sell	539,013 -5,201	-1%	-$188K	0.21%	102
2025 Q2	$20M	Buy	544,214 +87,029	+19%	+$2.88M	0.25%	98
2025 Q1	$14.2M	Buy	457,185 +57,862	+14%	+$1.83M	0.19%	106
2024 Q4	$10.2M	Sell	399,323 -70,657	-15%	-$1.87M	0.14%	121
2024 Q3	$13.3M	Buy	469,980 +41,918	+10%	+$1.16M	0.17%	111
2024 Q2	$11.3M	Sell	428,062 -14,318	-3%	-$397K	0.16%	121
2024 Q1	$13.4M	Buy	442,380 +287,741	+186%	+$8.48M	0.18%	118
2023 Q4	$4.34M	Buy	+154,639	New	+$4.25M	0.06%	160

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

River Road Asset Management's RPRX Position: Q2 2026 in Review

River Road Asset Management reduced its Royalty Pharma (RPRX) stake by 5.8% in Q2 2026, selling an estimated $1.22M and leaving 383,839 shares worth $21.5M. The position accounts for 0.24% of the portfolio, ranked #99.

River Road Asset Management first reported a position in RPRX in Q4 2023 and has held it in 11 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

River Road Asset Management held 383,839 shares of Royalty Pharma worth $21.5M as of Q2 2026.
River Road Asset Management sold 23,530 Royalty Pharma shares in Q2 2026, an estimated $1.22M.
Royalty Pharma made up 0.24% of River Road Asset Management's portfolio in Q2 2026, its #99 holding.
River Road Asset Management first reported a position in Royalty Pharma in Q4 2023 and has held it in 11 quarters since.
643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on River Road Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.